ALGS vs LYFT · rev $3.6M vs P/E 108, rev $5.79B
Aligos Therapeutics Inc (ALGS) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
ALGS currently screens at market cap $44.1M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the ALGS and LYFT stock pages for the full models.
Not investment advice.